期刊文献+

Perspectives of metal-organic framework nanosystem to overcome tumor drug resistance 被引量:1

原文传递
导出
摘要 Cancer is one of the most harmful diseases in the world, which causes huge numbers of deaths every year. Manydrugs have been developed to treat tumors. However, drug resistance usually develops after a period of time,which greatly weakens the therapeutic effect. Tumor drug resistance is characterized by blocking the action ofanticancer drugs, resisting apoptosis and DNA repair, and evading immune recognition. To tackle tumor drugresistance, many engineered drug delivery systems (DDS) have been developed. Metal-organic frameworks(MOFs) are one kind of emerging and promising nanocarriers for DDS with high surface area and abundant activesites that make the functionalization simpler and more efficient. These features enable MOFs to achieveadvantages easily towards other materials. In this review, we highlight the main mechanisms of tumor drugresistance and the characteristics of MOFs. The applications and opportunities of MOF-based DDS to overcometumor drug resistance are also discussed, shedding light on the future development of MOFs to address tumor drugresistance.
出处 《Cancer Drug Resistance》 2022年第4期954-970,共17页 癌症耐药(英文)
  • 相关文献

同被引文献18

引证文献1

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部